Epstein File EFTA00687759: Sara Jacobs and Jacobs (DS9)

Epstein Index›Documents›EFTA00687759

⚡IMPACT LEVEL 3 — NOTEWORTHY

Epstein File EFTA00687759: Sara Jacobs and Jacobs (DS9)

CorrespondenceDate unavailableEFTA006877592 keyword hits

0

views

0

shares

0

reactions

1

persons

0

keywords

3

excerpts

This is an email from Alice Jacobs to Denise Marston dated August 2, 2011, announcing that IMDx introduced a CE-marked assay for C. difficile for the European market. The email includes a quote from Alice Jacobs, MD, discussing pathogen identification in healthcare.

👤 Named in This Document

Sara Jacobs

🔑 Evidence Keywords

📋 Key Excerpts3

PersonKeyword

Excerpt 1

From: "Alice **Jacobs**" To: "Denise Marston" Subject: IMDx Introduces CE-marked Assay for C. difficile for European Market Date: Tue, 02 Aug 2011 23:45:37

Excerpt 2

Early identification of pathogens is critical in improving patient healthcare, shortening hospital stays, and reducing expenses," says Alice **Jacobs**, MD

Excerpt 3

**Jacobs**, M.D.